ORTHOSERA
OrthoSera is a regenerative medicine company that develops serum-based orthobiologics with the first product launched in 2015. It harnesses the power of blood serum for human diseases. The company develops serum-based orthobiologics and markets coating technology for human dental bone grafts. It offers BoneAlbumin, an albumin coated bone allograft used in orthopedics and dentistry. The company was founded in 2012 and is based in Krems an der Donau, Austria. It has subsidiaries locations in the United States and Hungary.
ORTHOSERA
Industry:
Health Care Life Science
Founded:
2012-01-01
Address:
Krems, Niederosterreich, Austria
Country:
Austria
Website Url:
http://www.orthosera.com
Total Employee:
11+
Status:
Active
Contact:
+43 664 883 16206
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content WordPress 6.0 COVID-19 Gravatar Profiles
Current Employees Featured
Founder
Investors List
FastVentures
FastVentures investment in Series B - OrthoSera
FastVentures
FastVentures investment in Series A - OrthoSera
Official Site Inspections
http://www.orthosera.com
- Host name: 193.201.188.82
- IP address: 193.201.188.82
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "OrthoSera"
OrthoSera - Crunchbase Company Profile & Funding
OrthoSera is a regenerative medicine company that develops serum-based orthobiologics with the first product launched in 2015. It harnesses the power of blood serum for human diseases. โฆSee details»
About us - OrthoSera
Our team Board members Zsombor Lacza, MD PhD DSc Founder, executive board member E-mail: [email protected] Linkedin Telephone: +36-30-5249554 Attila Várkonyi โฆSee details»
OrthoSera
OrthoSera Medical is a speciality pharma company focusing on innovative blood derivatives for regenerative medicine. A serum albumin enhanced bone allograft is in clinical use since 2015 โฆSee details»
OrthoSera Company Profile 2024: Valuation, Funding & Investors
OrthoSera General Information Description. Producer of a novel hyperacute serum intended to provide treatment of dental and musculoskeletal indications. The company's serum harnessed โฆSee details»
Imprint - OrthoSera
The company is registered in the capital courtโs company register at number 01-10-142674. OrthoSera Medical Zrt. Tax number: 28765592-2-43 Headquarters: 1123 Budapest, Alkotás โฆSee details»
OrthoSera GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore OrthoSera GmbH with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 18 literature.See details»
OrthoSera - Crunchbase
OrthoSera is a regenerative medicine company that develops serum-based orthobiologics with the first product launched in 2015. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
OrthoSera GmbH - Life-Sciences-Europe.com
Nov 26, 2015 Upcoming Events. BIO-Europe 2024 Stockholm; PEGS Europe 2024 Barcelona; UBS Global Healthcare Conference 2024 Rancho Palos Verdes; Guggenheim Global โฆSee details»
Orthosera - Products, Competitors, Financials, Employees, โฆ
Orthosera is a leader in blood serum development, focusing on the utilization of blood's regenerative capabilities in the medical treatment sector. Use the CB Insights Platform to โฆSee details»
OrthoSera - Tech Stack, Apps, Patents & Trademarks - Crunchbase
OrthoSera is a regenerative medicine company that develops serum-based orthobiologics with the first product launched in 2015. Search Crunchbase. Start Free Trial . Chrome Extension. โฆSee details»
Orthosera Dental Company Profile - Office Locations ... - Craft
Orthosera Dental is a medicine company harnessing the power of blood serum for human diseases. It provides bone substitutes, biofilm eraser, and membrane products.See details»
orthosera.com - OrthoSera Hungary - Ortho Sera - Sur.ly
OrthoSera is a regenerative medicine company harnessing the power of blood serum for human diseases. https://orthosera.com Safety status. Safe. Server location. United Kingdom. Domain โฆSee details»
OrthoSera - Funding, Financials, Valuation & Investors - Crunchbase
Jan 5, 2017 OrthoSera is a regenerative medicine company that develops serum-based orthobiologics with the first product launched in 2015. Search Crunchbase. ... How much โฆSee details»
Lacerta Technologies GmbH - Life-Sciences-Europe.com
Jan 1, 2012 OrthoSera (Group) Today: OrthoSera GmbH : Successor: OrthoSera GmbH: Industry: medical device : Industry 2: tissue engineering / regenerative medicine: Person: โฆSee details»
OrthoSera
Az OrthoSera BoneAlbumin terméke, amelyet több kettลs-vak klinikai vizsgálatban használtak, már 7 éves utánkövetéssel is igazolta, hogy a szérum hozzáadása jelentลsen javítja a klinikai โฆSee details»
BioNTech R&D (Austria) GmbH - Life Sciences Directory
Organization type RDM biotech/pharma Region Vienna Cluster LISAvienna Focus human health Profile. BioNTech R&D Austria, a wholly owned subsidiary of BioNTech SE since October โฆSee details»
OrthoSera - Contacts, Employees, Board Members, Advisors
Organization. OrthoSera . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. OrthoSera has 2 โฆSee details»
Plasma donation - OrthoSera
The development of OrthoSera is a concentrated, pooled serum that can be produced from the plasma of up to 100 recovered patients, and during the next wave of epidemics, a targeted โฆSee details»
Home Page - ORTHOTICA LABS
Call us at 1-888-895-1305 or book a meeting with Orthotica Labs to learn more.See details»
Knowledge base Archives - OrthoSera
Effects of Blood-Derived Products on Cellular Senescence and Inflammatory Response: A Study on Skin Rejuvenation. Blood-derived products, such as citrate platelet-rich plasma (CPRP) โฆSee details»